{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:55:58Z","timestamp":1789232158993,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2024IL0020"],"award-info":[{"award-number":["2024IL0020"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jiac.2023.10.026","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T10:30:44Z","timestamp":1699180244000},"page":"366-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency"],"prefix":"10.1016","volume":"30","author":[{"given":"Somi","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Reum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Woon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heungsup","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-0318","authenticated-orcid":false,"given":"Euijin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongman","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Oh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9939-3227","authenticated-orcid":false,"given":"Eun Hee","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-3185","authenticated-orcid":false,"given":"Yong Pil","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jiac.2023.10.026_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jiac.2023.10.026_bib2","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.1503\/cmaj.211698","article-title":"Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial","volume":"194","author":"Ali","year":"2022","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"3","key":"10.1016\/j.jiac.2023.10.026_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3071","article-title":"Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19","volume":"4","author":"Garibaldi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.jiac.2023.10.026_bib4","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/jps.22109","article-title":"Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)","volume":"99","author":"Luke","year":"2010","journal-title":"J Pharmaceut Sci"},{"issue":"2","key":"10.1016\/j.jiac.2023.10.026_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.34067\/KID.0006152021","article-title":"A propensity score-matched observational study of remdesivir in patients with COVID-19 and severe kidney disease","volume":"3","author":"Seethapathy","year":"2022","journal-title":"Kidney360."},{"issue":"8","key":"10.1016\/j.jiac.2023.10.026_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.29236","article-title":"Remdesivir in patients with severe kidney dysfunction: a secondary analysis of the CATCO randomized trial","volume":"5","author":"Cheng","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2023.10.026_bib7","series-title":"Clinical management of COVID-19: living guideline","author":"Who","year":"2022"},{"issue":"1","key":"10.1016\/j.jiac.2023.10.026_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ckj\/sfs160","article-title":"The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review","volume":"6","author":"Lopes","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jiac.2023.10.026_bib9","series-title":"Severity grading in drug induced liver injury","year":"2019"},{"issue":"5","key":"10.1016\/j.jiac.2023.10.026_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40262-021-00984-5","article-title":"Pharmacokinetic, pharmacodynamic, and drug-interaction profile of remdesivir, a SARS-CoV-2 replication inhibitor","volume":"60","author":"Humeniuk","year":"2021","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jiac.2023.10.026_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1179\/joc.2008.20.1.93","article-title":"Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function","volume":"20","author":"Alvarez-Lerma","year":"2008","journal-title":"J Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2023.10.026_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/cir969","article-title":"Administration of voriconazole in patients with renal dysfunction","volume":"54","author":"Neofytos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jiac.2023.10.026_bib13","doi-asserted-by":"crossref","first-page":"e3990","DOI":"10.1093\/cid\/ciaa1851","article-title":"Remdesivir use in the setting of severe renal impairment: a theoretical concern or real risk?","volume":"73","author":"Pettit","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2023.10.026_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s15010-022-01850-7","article-title":"Is remdesivir safe in patients with renal impairment? Experience at a large tertiary urban medical center","volume":"51","author":"Sunny","year":"2023","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.jiac.2023.10.026_bib15","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1097\/MJT.0000000000001543","article-title":"Remdesivir administration in COVID-19 patients with renal impairment: a systematic review","volume":"29","author":"Davoudi-Monfared","year":"2022","journal-title":"Am J Therapeut"},{"issue":"1","key":"10.1016\/j.jiac.2023.10.026_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-021-02244-x","article-title":"Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19","volume":"22","author":"Xu","year":"2021","journal-title":"BMC Nephrol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23002714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:52Z","timestamp":1761160012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23002714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1341321X23002714"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.026","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical safety of remdesivir therapy in COVID-19 patients with renal insufficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}